Sofinnova Partners, a European life sciences venture capital firm based in Paris, London, and Milan, has collaborated with NVIDIA to support its portfolio of life sciences startups.

The collaboration delivers significant Graphics Processing Unit (GPU) credits to select Sofinnova portfolio companies, effectively giving access to the same computational firepower used by tech companies in Silicon Valley.

Amidst increasing demand for computer resources driven by AI, Sofinnova’s portfolio companies will be able to access NVIDIA Blackwell and other NVIDIA architecture GPUs via NVIDIA DGX Cloud Lepton, an AI platform and marketplace connecting developers to global AI infrastructure.

BioCorteX, Bioptimus, Cure51 and Latent Labs—four promising European startups—will gain access to computing resources through DGX Cloud Lepton, enabling them to process biological data sets and run computational models that would have taken months, completing them in days.  

Cure51, a company decoding the biology of cancer survivors, tested NVIDIA Parabricks, a GPU-accelerated genomics toolkit, and achieved up to 17 times faster processing with NVIDIA H100 GPUs and more than two times cost savings with NVIDIA L4 GPUs compared to their CPU baseline—dramatically accelerating their ability to analyse complex genomic data and scale their survivor-based insights.  

“This collaboration supercharges computation for life sciences innovation,” said Antoine Papiernik, Chairman and Managing Partner at Sofinnova Partners. “The convergence of biology, AI, computation, and data isn’t just our investment thesis—it’s the defining battleground of the next decade. From our Digital Medicine strategy to our own proprietary AI platform Sofinnova.ai, we recognise the transformative potential of AI across our entire domain. By securing access to NVIDIA’s infrastructure, we’re not just funding companies; we’re empowering them with the computational backbone needed to outperform incumbents and redefine what’s possible in drug discovery, precision medicine, and scalable solutions that address both human health and sustainability.”

Megan Thomas, Multimedia Editor, DDW